NCT00581555View on ClinicalTrials.gov

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Psoriasis

Interventions

DRUG

Etanercept

Etanercept 50 mg QW initiated during taper of ciclosporin

OTHER

Placebo

Randomized to placebo during taper of ciclosporin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY